Open original FDA record ↗Recall record
- FDA identifier
- Z-3299-2024
- Company in FDA record
- ARROW INTERNATIONAL Inc.
- FDA classification date
- Sep 26, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Reports have been received regarding open seals on the packaging.
Source facts
- Action
- The recalling firm issued letters dated July-2024 via Fed Ex 2-day mail on 7/26/2024. The letter provided a description of the problem and immediate actions required. Medical facilities were requested to immediately check their inventory for the affected product and cease use and distribution of it. The product is to be quarantined immediately. If the facility has the impacted product, they are to indicate so on the Acknowledgement Form enclosed with the letter and FAX it to the firm. A customer service representative will contact the medical facility with a Return Goods Authorization (RGA) Number and provide instructions for the return of the product. Distributors are requested to provide the field safety notice to all customers who have received the impacted product. Each of the distributor's customers are required to complete the Acknowledgment Form and return it to the distributor. Additionally, the distributor is to check their inventory for the impacted product, cease use and distribution of it, and quarantine it. If the product has been further distributed outside of the distributor's country, they are to notify Teleflex Customer Service by return email.
- Initiated
- 2024-07-26
- Root cause
- Nonconforming Material/Component
- Distribution
- US Nationwide distribution in the states of CA, FL, GA, IL, MA, ME, MI, NC, NY, PA, and WV. There was government distribution.
- Recall number
- Z-3299-2024
- Recall status
- Open, Classified
- CDRH record ID
- 209774
- FDA classified
- 2024-09-26
- Recall event number
- 95228